GMP/Biomanufacturing is a subset of the life sciences sector. It encompasses the “downstream” facilities and real estate used by biotechnology and biopharmaceutical companies as they develop, test, and manufacture medicines and therapies. GMP space is mission-critical for these companies. It is only within a GMP facility that businesses can successfully trial products, move through approval processes, and – ultimately – bring important treatments to market.
Oxford recognizes the great importance of high-quality, efficient GMP space. Substantially growing our life sciences business represents one of our highest conviction investment strategies and top priorities, and GMP real estate is a natural and promising extension of that work. We are committed to doing what is right for our customers, and we see opportunity to serve them through this unique asset class, bringing new efficiencies to the production of critical therapies. And we recognize that Oxford is uniquely positioned to service this subsector. GMP space bears similarities to industrial real estate – a vertical in which Oxford is an established global leader.